SCHEMBL27712207

SCHEMBL27712207

O=C(O)c1cc(CCCC2CCCCC2)cc(C(=O)O)c1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.41
▸ PPM1D O15297 2/20 0.41
▸ KDM4C Q9H3R0 1/20 0.40
▸ GPR84 Q9NQS5 1/20 0.40
▸ SLC18A3 Q16572 1/20 0.40
▸ SPHK1 Q9NYA1 2/20 0.39
▸ DAO P14920 1/20 0.39
▸ CEL P19835 1/20 0.39
▸ THRA P10827 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ LNPEP Q9UIQ6 1/20 0.38
▸ KMO O15229 1/20 0.37
▸ SIGMAR1 Q99720 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28138572 0.90 DAO (0.48) MCL1PPM1DKDM4CDAOTHRA
SCHEMBL27975645 0.88 DAO (0.45) PPM1DKDM4CDAOTHRATHRB
SCHEMBL27692114 0.86 LNPEP (0.37) MCL1SLC18A3LNPEP
SCHEMBL2197741 0.85 PPM1D (0.53) MCL1PPM1DKDM4CSLC18A3KMO
SCHEMBL27692208 0.84 LNPEP (0.36) PPM1DSLC18A3LNPEP
SCHEMBL28133767 0.81 GPR84 (0.38) PPM1DGPR84DAO
SCHEMBL10080510 0.78 GRIN2D (0.57) PPM1DSPHK1KMT2ALNPEP
SCHEMBL1149201 0.77 DAO (0.49) MCL1GPR84SLC18A3DAORAB9A
SCHEMBL11677284 0.76 GPR84 (0.50) GPR84SLC18A3DAOCEL
SCHEMBL16182351 0.73 HSD17B10 (0.53) SLC18A3SPHK1THRATHRBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101128435-A Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders ASTRAZENECA AB (SE) 2008-02-20 — — CN disclosed
Send feedback